Center for the Discovery of New Medicines
Therapeutic Approaches: Biologics, Small Molecules, Vaccines
Therapeutic Areas of Expertise: Cardiology, Immunology, Infectious Diseases, Metabolic Disorders, Neurological Disorders, Oncology, Psychiatric Disorders, Pain
The Center for Discovery of New Medicines (CDNM) brings together University of Michigan experts in all areas of the drug discovery enterpriseincluding medicinal chemists, structural biologists, pharmacologists and pharmaceutics and drug metabolism researchersto support early-stage, innovative projects across the university. As a virtual center, the CDNM provides financial support and mentorship to researchers with promising potential therapeutics in order to leverage existing investments in informatics, robotics and high-throughput screening and to promote new opportunities in drug discovery and development.
Collaboration across the scientific disciplines is fundamental to transformative scientific discovery. U-M scientists are tackling challenging targets like protein-protein interactions, gene transcription mechanisms and protein folding/chaperonestargets that require a high level of investment and involve substantial risk. Orphan diseases, tuberculosis, drug-resistant bacteria, lethal viral infections, cancer, neurodegenerative diseases and depression represent important areas of unmet medical need that are being studied by researchers supported by the CDNM.
The CDNM achieves its mission by providing academic leadership and centralized access to expertise in drug discovery, strongcore facilitiesand infrastructure, and pilot funds for faculty projects.
Sources of Funding: Federal/State, Philanthropy, Industry Partnerships, Disease Foundations, University
Institutional Affiliation(s): University of Michigan
Life Sciences Institute
210 Washtenaw Ave, 3358
Center/Program Start Date: 2012
Number of Employees: 25